Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who had at least one completely blocked coronary artery (a type of long-term, total blockage called a CTO) treated at the relevant hospital between January 2011 and December 2017
Who may not be able to join:
- People who had a severe type of heart attack called an ST-segment elevation myocardial infarction (STEMI) (confirm with trial site)
- People who have previously had open-heart bypass surgery to treat blocked coronary arteries
- People who experienced cardiogenic shock, a serious condition where the heart suddenly cannot pump enough blood to meet the body's needs
- People who have or had a malignant (cancerous) tumour
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Leilei Chen, The First Affiliated Hospital with Nanjing Medical University
Phone: 0086 15256095215
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
major adverse cardiac cerebrovascular events (MACCE)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.